Hyper-Personalized Medicine Using Patient Derived Xenografts (PDXovo) for Metastatic Solid Tumors

NCT04602702 · clinicaltrials.gov ↗

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Kidney Neoplasm
Carcinoma, Renal Cell
Metastatic Solid Tumor

Sponsor

Sunnybrook Health Sciences Centre